Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.082 | 0.03 |
mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.03 |
mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.072 | 0.03 |
mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.11 | 0.03 |
mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |